E815
TEAS SECTION 8 & 15 RECEIVED
06/16/2026
Back to search
Official data from USPTO
WE SEE WHAT'S NEXT ONCOLOGY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
06/17/2026
Trademark type
Combined
Nice classes
25, 35, 42
Filing date
06/06/2018
Registration date
12/24/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/24/2019
Last transaction
06/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/18/2018
First use in commerce
07/18/2018
Drawing code
3
Owner type
16
Owner location
San Antonio, TX, US
Examiner
SPILS, CAROL A
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized words "We see what's" above the letters "n" and "e" of the word "next" wherein the lines intersecting to form the "x" also form an outline of a person's legs and raised arms with a circle above the "x" as the head and the word "ONCOLOGY" centered below "next" with the right leg of the "x" extending downward to the right of the word "ONCOLOGY".
Holders and representatives
Holders
New Experimental Therapeutics of San Antonio, LLC
Representatives
Arlene D. Hanks Moore & Van Allen PLLC
Technical classification
Nice Classes
Class 25Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 25
T-shirts
Class 35
Providing a website featuring business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval for medical research purposes
Class 42
Medical and scientific researchconducting clinical trials for others; clinical research in the fields of cancer and pharmacology; providing a website featuring medical and scientific research consulting services for others in the field of designplanningimplementation project management of clinical trials for medical research purposes
Publications
History of USPTO decisions and trademark events.
32 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/08/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/08/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/08/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/08/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/08/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/24/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/24/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/19/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/18/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/12/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/12/2019
IUAF
USE AMENDMENT FILED
10/30/2019
EISU
TEAS STATEMENT OF USE RECEIVED
10/30/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/21/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/21/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/30/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/05/2019
PUBO
PUBLISHED FOR OPPOSITION
03/05/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/13/2019
ALIE
ASSIGNED TO LIE
01/25/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/07/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/07/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/03/2018
GNRT
NON-FINAL ACTION E-MAILED
10/03/2018
CNRT
NON-FINAL ACTION WRITTEN
10/03/2018
DOCK
ASSIGNED TO EXAMINER
09/24/2018
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/13/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/12/2018
NWAP
NEW APPLICATION ENTERED
06/09/2018
Continuous trademark protection
Get notified about every new filing that threatens WE SEE WHAT'S NEXT ONCOLOGY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.